Pediatric Grand Rounds (CME): Advancing Treatment for Neuroblastoma Through Collaboration: A Pediatric Oncology Paradigm

Anne T. Bass Lecture Series in Hematology, Oncology and Stem Cell Transplantation
Advancing Treatment for Neuroblastoma Through Collaboration: A Pediatric Oncology Paradigm

SPEAKER
Susan Cohn, MD
Professor of Pediatrics and Director of Clinical Sciences
The University of Chicago Medicine

SESSION DESCRIPTION
This session will review the advances that have been made in neuroblastoma treatment though sequential cooperative group clinical trials. We will review clinical and biological biomarkers that are prognostic of outcome that have formed the basis of risk-stratified treatment approaches. In addition, we will highlight international efforts to create a uniform risk classification system and will discuss a neuroblastoma data resource available to the research community around the world: the INRG Data Commons.

EDUCATION GOALS

• Identify clinical and biological prognostic markers that are used to distinguish low, intermediate, and high risk disease.
• Understand current risk based treatment strategies for patients with high risk neuroblastoma and the role of immunotherapy with anti-GD2 antibodies.
• Recognize treatment related acute and long term complications observed in high risk neuroblastoma survivors.
   

ZOOM 
Register for Webinar

CME ACCREDITATION
This session is eligible for CME credit. To claim CME credit, text code to (844) 560-1904 to confirm attendance. A new code will be provided at beginning of the session.